Key result
A 58-year-old woman developed stage IV congestive heart failure 7 years after completing doxorubicin treatment for ovarian carcinoma, with occult dysfunction detected 6 years prior.
Why the study?
Can doxorubicin treatment lead to late-onset congestive heart failure in adult patients?
Population
58-year-old woman with a history of carcinoma of the ovary treated with doxorubicin
Design
Case_report
Follow-up
7 years after completion of treatment
Authors
Loading...
Late doxorubicin exposure may cause very late HF; leaves open optimal long-term monitoring strategies.
Case Report (n=1)
Can doxorubicin treatment lead to late-onset congestive heart failure in adult patients?
This case highlights the rare occurrence of late-onset clinical congestive heart failure in an adult years after doxorubicin therapy, emphasizing the potential value of long-term cardiac monitoring.
Lishner et al. (1992) conducted a case report in Late doxorubicin cardiotoxicity (n=1). Doxorubicin was evaluated on Development of stage IV congestive heart failure. A 58-year-old woman developed stage IV congestive heart failure 7 years after completing doxorubicin treatment for ovarian carcinoma, with occult dysfunction detected 6 years prior.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: